These results corroborate Cav-1 to have direct effects on RCC patho-biology and support Cav-1 as a valuable biomarker in RCC especially when incorporated with other markers of biologically relevant signalling pathways such as activated ERK. Here, CAV1 is linked to renal cell carcinoma.